1. Home
  2. CNVS vs ACET Comparison

CNVS vs ACET Comparison

Compare CNVS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$3.10

Market Cap

60.1M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.32

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNVS
ACET
Founded
2000
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.1M
71.3M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CNVS
ACET
Price
$3.10
$7.32
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$9.00
$65.33
AVG Volume (30 Days)
434.7K
183.6K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
108.99
59.82
EPS
N/A
N/A
Revenue
$78,181,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$30.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.13
N/A
52 Week Low
$1.77
$0.45
52 Week High
$7.39
$9.05

Technical Indicators

Market Signals
Indicator
CNVS
ACET
Relative Strength Index (RSI) 70.72 53.90
Support Level $2.47 $0.62
Resistance Level $3.49 $8.74
Average True Range (ATR) 0.29 0.63
MACD 0.09 -0.08
Stochastic Oscillator 79.65 46.63

Price Performance

Historical Comparison
CNVS
ACET

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: